Summary: Sean Ha, president of HoneyNaps USA Inc, received the 2023 Artificial Intelligence Industry Contributor prize from South Korea’s Ministry of Science and ICT for his work in developing SOMNUM, an AI-powered sleep disorder analysis algorithm. Recently granted FDA 510(k) clearance, SOMNUM uses deep learning to analyze biosignals in real-time, aiding healthcare providers in diagnostics. Ha aims to expand the technology’s benefits globally.
Key Takeaways:
- Sean Ha received the 2023 Artificial Intelligence Industry Contributor prize from South Korea’s Ministry of Science and ICT for his contributions to AI and sleep disorder technology.
- Ha developed SOMNUM, an AI-powered algorithm for real-time sleep disorder analysis, which recently received FDA 510(k) clearance.
- Ha is committed to expanding the benefits of Korean AI technologies to enhance healthcare systems and patient care in the US and globally.
Sean Ha (Tae Kyoung Ha), the president of HoneyNaps USA Inc, was awarded the 2023 Artificial Intelligence Industry Contributor prize by South Korea’s Ministry of Science and ICT in recognition of his contribution to the development of artificial intelligence (AI).
Ha developed SOMNUM, an AI-powered sleep disorder analysis algorithm that recently was granted US Food and Drug Administration 510(k) clearance. SOMNUM leverages deep learning-based AI to perform real-time analysis of vast volumes of multi-channel/time series biosignals to deliver diagnostic information to providers.
Ha spearheaded the business’s expansion by commercializing the biosignal-based real-time AI model.
Regarding the Ministry’s award of the prize, Ha says in a release, “I’m pleased by the high assessment accorded to the AI technology co-developed by our company’s development teams and medical teams from prestigious university hospitals for nine years.”
He adds in a release, “I’ll actively pursue identifying areas where Korean AI technologies can benefit both world-class healthcare delivery systems and patients in the US. I’ll also devote myself in line with the company’s philosophy, ‘We contribute to selective human health improvement, even for just one person.’”
Photo 100994328 | 3d © Kittipong Jirasukhanont | Dreamstime.com
